Suboptimal Care of Peanut Allergic Children in Germany Concerning Professional Dietary Advice and the Supply of Self-Injectable Epinephrine

Methods 63 peanut allergic children (median: age 6 years; peanutspecific IgE 73,5kU/l) who participated in an oral immunotherapy (OIT)-study were enrolled. Data concerning age of diagnosis, provision with self-injectable epinephrine, professional advice and performance of a peanut-free diet as well as the characterization of accidental allergic reactions to peanut (grade of severity I-V) were collected at their baseline visit of the OIT-study.